Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report

ConclusionsThe present study confirms a poor outcome of patients with stroma-high tumours. Low CDX2 expression in tumours with a high stromal content identified patients with a particularly poor prognosis. The present study did not reveal a clear difference in TSR associated with CDX2 status and survival. This method, solely based on microscopy, identifies patients who have a high risk of relapse and a poor outcome, and who may benefit from targeted therapy.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research